Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

DAIICHI S : Notice on Details of the Share Options

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/12/2011 | 10:20am CEST
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126

http://www.daiichisankyo.com/Notice on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)

Reference

Date of Board of Directors resolution: June 27, 2011

###
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DAIICHI SANKYO COMPANY, LI
09/22 INOVALON : Announces Agreement with Daiichi Sankyo, Inc. to Support Outcomes-Bas..
09/21 DAIICHI SANKYO : Presents New Data for DS-8201 in Multiple HER2-Expressing Solid..
09/21 DAIICHI SANKYO : MD Anderson and Daiichi Sankyo enter research collaboration to ..
09/21 REPORTS SUMMARIZE MEDICINAL CHEMISTR : A potent orally active hepcidin productio..
09/19 DAIICHI SANKYO : MD Anderson and Daiichi Sankyo Enter Research Collaboration to ..
09/19 DAIICHI SANKYO : Listed on the Dow Jones Sustainability Indices World Index
09/18 DAIICHI SANKYO : Moves high court to stop payments by religare
09/15 DAIICHI SANKYO : MD Anderson and Daiichi Sankyo Enter Research Collaboration to ..
09/14 DAIICHI SANKYO : Sanford Burnham Prebys and Daiichi Sankyo Announce Enrollment o..
09/14 DAIICHI SANKYO : Presents New Data for DS 8201 in Multiple HER2 Expressing Solid..
More news
News from SeekingAlpha
09/14 Daiichi teams up with MD Anderson to accelerate new leukemia therapies
08/31 Daiichi backs out of hydrocodone development partnership with Charleston Labs..
08/31 Daiichi Sankyo's mirogabalin successful in late-stage neuropathic pain study
08/31 AstraZeneca tried to buy Daiichi Sankyo last year - report
08/28 Bristol-Myers and Daiichi Sankyo team up to evaluate Opdivo/DS-8201 combo in ..
Financials ( JPY)
Sales 2018 927 B
EBIT 2018 -
Net income 2018 66 206 M
Finance 2018 361 B
Yield 2018 2,73%
P/E ratio 2018 25,65
P/E ratio 2019 27,55
EV / Sales 2018 1,57x
EV / Sales 2019 1,70x
Capitalization 1 819 B
Chart DAIICHI SANKYO COMPANY, LI
Duration : Period :
DAIICHI SANKYO COMPANY, LI Technical Analysis Chart | 4568 | JP3475350009 | 4-Traders
Technical analysis trends DAIICHI SANKYO COMPANY, LI
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 2 480  JPY
Spread / Average Target -3,3%
EPS Revisions
Managers
NameTitle
Joji Nakayama President, CEO & Representative Director
Kentaro Takamura IR Contact, Manager-Finance & Accounting
Glenn J. Gormley Senior Managing Executive Officer, Head-R&D
Masahiko Ohtsuki Executive Officer & Senior Manager-Research
Kazunori Hirokawa Representative Director, VP & GM-Administration
Sector and Competitors
1st jan.Capitalization (M$)
DAIICHI SANKYO COMPANY, LIMITED7.25%16 138
JOHNSON & JOHNSON15.63%353 617
NOVARTIS11.88%223 850
ROCHE HOLDING LTD.6.19%221 926
PFIZER10.81%214 206
MERCK AND COMPANY11.75%178 914